Biomarin Pharmaceutical Inc (NAS:BMRN)
$ 65.42 0.54 (0.83%) Market Cap: 12.47 Bil Enterprise Value: 12.14 Bil PE Ratio: 39.17 PB Ratio: 2.30 GF Score: 72/100

Biomarin Pharmaceutical Inc at Morgan Stanley Global Healthcare Conference Transcript

Sep 11, 2023 / 02:00PM GMT
Release Date Price: $90.86 (+0.74%)
Vikram Purohit
Morgan Stanley, Research Division - Equity Analyst

Okay. Go ahead and get started. Welcome, everyone. This will be a fireside chat with BioMarin. My name is Vikram Purohit. I'm one of the biotech analysts with the research team. Happy to have with me the CFO of BioMarin, Brian Mueller, with us. Thanks so much for joining us, Brian.

Before we get into the session, I just need to read a brief disclosure statement. For important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/research disclosures. And if you have any questions, please reach out to your Morgan Stanley sales representative.

So with that, let's get started. Brian, we'd just love to open it to you for some opening remarks on the business and some key highlights you think that BioMarin's achieved throughout the year and then we'll go from there.

Brian R. Mueller
BioMarin Pharmaceutical Inc. - CFO & Executive VP

Yes. Thanks. Appreciate it

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot